{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:31:09Z","timestamp":1718778669989},"reference-count":13,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T00:00:00Z","timestamp":1119312000000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> The treatment of thrombotic thrombocytopenic purpura requires plasma exchange using fresh frozen plasma as a replacement solution once or even twice daily. If citrate anticoagulation is needed, the citrate load (both from fresh frozen plasma and citrate as an anticoagulant) can be significant, causing metabolic complications. The aim of our report is to present our experience with citrate anticoagulation in a patient with thrombotic thrombocytopenic purpura treated with daily membrane plasma exchange. Twenty\u2010six plasma exchange procedures were performed during 20\u2003days of treatment in a 46\u2010year\u2010old female. The blood flow was 98\u2003\u00b1\u20038\u2003mL\/min; 4% trisodium citrate was infused into the arterial line (134\u2003\u00b1\u200311\u2003mL\/h) and 1\u2003M CaCl<jats:sub>2<\/jats:sub> into the venous line (11.4\u2003\u00b1\u20031.8\u2003mL\/h). Fresh frozen plasma (first 7 procedures) or cryo\u2010poor plasma (19 procedures) were used as a replacement solution, 3176\u2003\u00b1\u2003536\u2003mL per procedure. A total of 88,930\u2003mL of plasma was exchanged. No serious side\u2010effects occurred. iCa before plasma exchange was significantly higher than afterwards (1.23\u2003\u00b1\u20030.12 vs. 1.12\u2003\u00b1\u20030.12, <jats:italic>P<\/jats:italic>\u2003=\u20030.0047). Significant alkalosis occurred after three plasma exchanges (pH\u20037.64, bicarbonate 36.2\u2003mmol\/L), and was corrected by 3\u2010h heparin\u2010free hemodialysis with dialysate as follows: K 4.0\u2003mmol\/L, calcium 1.5\u2003mmol\/L, and bicarbonate set to 24\u2003mmol\/L. After dialysis, pH was 7.45 and bicarbonate 29.4\u2003mmol\/L. Another (2\u2010h) heparin\u2010free hemodialysis procedure was repeated after six plasma exchanges. Citrate anticoagulation can be safely performed in patients treated with plasma exchange once or twice daily. Periodically performed short heparin\u2010free hemodialysis can correct metabolic alkalosis and attenuate the citrate load.<\/jats:p>","DOI":"10.1111\/j.1774-9987.2005.00267.x","type":"journal-article","created":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T17:12:47Z","timestamp":1119373967000},"page":"258-261","source":"Crossref","is-referenced-by-count":15,"title":["Citrate Anticoagulation During Plasma Exchange in a Patient With Thrombotic Thrombocytopenic Purpura: Short Heparin\u2010free Hemodialysis Helps to Attenuate Citrate Load"],"prefix":"10.1111","volume":"9","author":[{"given":"Jadranka","family":"Buturovi\u0107\u2010Ponikvar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreja Marn","family":"Pernat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ponikvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,6,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-0968.2003.00113.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198302033080506"},{"key":"e_1_2_6_4_2","first-page":"404","article-title":"Anticoagulant and membrane effects on humoral and cellular changer during plasmapheresis","volume":"34","author":"Omokawa S","year":"1988","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_2_6_5_2","first-page":"1228","article-title":"Citrate versus heparin anticoagulation in chronic hemodialysis patients","volume":"8","author":"Janssen MJFM","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.1998.06239.x"},{"key":"e_1_2_6_7_2","first-page":"A39","article-title":"Simultaneous protein A immunoadsorption and hemodialysis using citrate as the only anticoagulant in a patient with high risk of bleeding","volume":"15","author":"Ponikvar R","year":"1997","journal-title":"Blood Purif"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.1998.06268.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.300"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.112"},{"key":"e_1_2_6_11_2","first-page":"A499","article-title":"Hemodialysis in patients with high risk of hemorrhage: prostacyclin vs. citrate vs. heparin free HD","volume":"6","author":"Ponikvar R","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_12_2","first-page":"A332","article-title":"Sequential citrate\/heparin anticoagulation during hemodialysis with cuprophan membrane","volume":"21","author":"Buturovi\u0107 J","year":"1997","journal-title":"Artif Organs"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00671.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(87)80061-6"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1774-9987.2005.00267.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1774-9987.2005.00267.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:11:57Z","timestamp":1697055117000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1774-9987.2005.00267.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1774-9987.2005.00267.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1774-9987.2005.00267.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}